These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5064355)

  • 21. [Modifications of the habel test].
    Barth R; Jaeger O
    Zentralbl Bakteriol Orig; 1969; 209(3):279-88. PubMed ID: 5379826
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody response to human diploid cell antirabies vaccine in human volunteers--a preliminary study.
    Bhatia R; Ichhpujani RL; Rai Chowdhuri AN
    J Commun Dis; 1984 Mar; 16(1):70-3. PubMed ID: 12055790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on dynamics of antibodies in dogs vaccinated with various types of antirabies vaccines].
    SHEN RM; ORLOVA NN; TUREVICH ST; NAZAROV VA; BEZELIUK MI
    Vopr Virusol; 1957; 2(3):156-61. PubMed ID: 13530865
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunogenicity and feasibility of purified chick embryo cell vaccine.
    Sehgal S; Bhardwaj M; Bhattacharya D
    Indian Pediatr; 1994 Feb; 31(2):133-7. PubMed ID: 7875835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
    Deshpande AK; Londhe VA; Akarte S; Briggs D
    J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Iatrogenic impact of veterinary prophylaxis on man. Timeliness of serologic monitoring of antirabies immunity in the contaminated vaccinated animal].
    Lery L; Bijlenga G; Joubert L
    Bull Acad Natl Med; 1981 Jun; 165(6):753-9. PubMed ID: 7034895
    [No Abstract]   [Full Text] [Related]  

  • 27. Prospective immunogenicity study of multiple intradermal injections of rabies vaccine in an effort to obtain an early immune response without the use of immunoglobulin.
    Khawplod P; Wilde H; Tepsumethanon S; Limusanno S; Tantawichien T; Chomchey P; Ayuthaya AB; Wangroonsarb Y
    Clin Infect Dis; 2002 Dec; 35(12):1562-5. PubMed ID: 12471579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biological changes in a strain of influenza virus, cultured in mice vaccinated with antirabies vaccine].
    ATHANASIU P; PETRESCU A; GRUIA M; SARATEANU D
    Stud Cercet Inframicrobiol; 1959; 10():213-8. PubMed ID: 13794941
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased interleukin-10 associated with low IL-6 concentration correlated with greater survival rates in mice infected by rabies virus vaccinated against it and immunomodulated with P. acnes.
    Megid J; Kaneno R; Nozaki CN; Brito CJ; Almeida MF
    Comp Immunol Microbiol Infect Dis; 2004 Nov; 27(6):393-411. PubMed ID: 15325513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and clinico-immunological studies with rabies-cell culture and Hempt vaccine].
    Henne K; Apitzsch L; Hölzer E; Nitschke H; Sinnecker H; Sinnecker R; Zilske E
    Dtsch Gesundheitsw; 1972 Dec; 27(49):2337-41. PubMed ID: 4651192
    [No Abstract]   [Full Text] [Related]  

  • 31. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of neutralizing antibodies in the serum of persons vaccinated against rabies with Semple type vaccine].
    Serokowa D; Gawronowa H; Kreska B
    Przegl Epidemiol; 1969; 23(4):481-8. PubMed ID: 5369051
    [No Abstract]   [Full Text] [Related]  

  • 33. [Normal production of antibodies against the Semple type of anti-rabies vaccine in persons treated with paramethasone].
    Campillo Sainz C; López Pintado F; Núñez Rivera A
    Rev Invest Salud Publica; 1966; 26(3):193-200. PubMed ID: 5993038
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antirabies treatment with Fuenzalida-Palacios type vaccine].
    Fábrega FP; Sepúlveda CA
    Bol Oficina Sanit Panam; 1981 Mar; 90(3):211-7. PubMed ID: 6454421
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of the efficacy of the antirabies vaccines used for foxes in France.
    Masson E; Aubert MF; Barrat J; Vuillaume P
    Vet Res; 1996; 27(3):255-66. PubMed ID: 8767887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic value of lyophilized phenolized antirabies vaccine.
    VEERARAGHAVAN N; SUBRAHMANYAN TP
    Bull World Health Organ; 1961; 25(1):115-7. PubMed ID: 13925168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of antibody responses after vaccination with two inactivated rabies vaccines.
    Minke JM; Bouvet J; Cliquet F; Wasniewski M; Guiot AL; Lemaitre L; Cariou C; Cozette V; Vergne L; Guigal PM
    Vet Microbiol; 2009 Jan; 133(3):283-6. PubMed ID: 18757142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children.
    Vien NC; Feroldi E; Lang J
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):294-6. PubMed ID: 18191971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective efficacy of live- and dead-virus rabies vaccines in offspring (mice) of immune dams.
    Bell JF; Moore GJ; Raymond GH
    Am J Vet Res; 1970 Jun; 31(6):1055-8. PubMed ID: 5430696
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of rabies DNA vaccine using a recombinant plasmid.
    Rai N; Kaushik P; Rai A
    Acta Virol; 2005; 49(3):207-10. PubMed ID: 16178518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.